| 000 | 01167 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515144118.0 | ||
| 264 | 0 | _c20090327 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1878-5832 | ||
| 024 | 7 |
_a10.1016/j.drudis.2008.09.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLongstaff, Colin | |
| 245 | 0 | 0 |
_aHow do we assure the quality of biological medicines? _h[electronic resource] |
| 260 |
_bDrug discovery today _cJan 2009 |
||
| 300 |
_a50-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aBiological Products _xstandards |
| 650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aHeparin _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 |
_aStreptokinase _xstandards |
| 700 | 1 | _aWhitton, Colin M | |
| 700 | 1 | _aStebbings, Richard | |
| 700 | 1 | _aGray, Elaine | |
| 773 | 0 |
_tDrug discovery today _gvol. 14 _gno. 1-2 _gp. 50-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.drudis.2008.09.010 _zAvailable from publisher's website |
| 999 |
_c18414565 _d18414565 |
||